Navigation Links
BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome
Date:6/5/2008

bout MPS IVA

Mucopolysaccharidosis IVA (MPS IVA, also known as Morquio A Syndrome) is a disease characterized by deficient activity of N-acetylgalactosamine-6- sulfatase (GALNS) causing excessive lysosomal storage of keratan sulfate (KS). This excessive storage causes a systemic skeletal dysplasia, short stature, and joint abnormalities, which limit mobility and endurance. Malformation of the thorax impairs respiratory function, and odontoid hypoplasia and ligamentous laxity cause cervical spinal instability and potentially cord compression. Other symptoms may include hearing loss, corneal clouding, and heart valvular disease. Initial symptoms often become evident in the first five years of life. Depending on severity of the disease, age of diagnosis will vary.

The rate of incidence of MPS IVA is as yet unconfirmed, but estimates vary between 1 in 200,000 live births to 1 in 300,000 live births. Approximately 370 patients worldwide are currently registered in The International Morquio Organization (IMO) survey. An estimated 1,100 patients in the developed world have MPS VI and an estimated 3,000 patients in the developed world have MPS I.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include 6R-BH4 for cardiovascular in
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioMarin to Host Research and Development Day June 5th
2. BioMarin to Present at the Bank of America Healthcare Conference
3. BioMarin Announces First Quarter 2008 Financial Results
4. BioMarin to Present at the Morgan Stanley Healthcare Conference
5. BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET)
6. BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
9. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
10. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
11. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... The new research report, “Gas Insulated Switchgear ... (Primary & Secondary), and End-User (Transmission & Distribution, ... Generation) - Trends and Forecasts to 2019”, defines ... forecasting of the market size. , Browse more ... spread through 146 Pages and in-depth TOC on ...
(Date:10/27/2014)... New Q4-2014 incentives help SoundConnect partners ... leading unified communication and collaboration provider, launches new ... cloud-based audio and web/video conferencing solutions to their ... Q4 incentive partners will earn $400.00 ... licenses sold, now through December 31st, 2014. , ...
(Date:10/27/2014)... Investor-Edge has initiated coverage on the following ... Insmed Inc. (NASDAQ: INSM ), BioCryst Pharmaceuticals ... DYAX ), and Oncothyreon Inc. (NASDAQ: ONTY). ... at: http://investor-edge.com/register . On Friday, October ... 0.69%, the Dow Jones Industrial Average advanced 0.76%, to ...
(Date:10/25/2014)... (PRWEB) October 23, 2014 BioProcess ... winners for the 2014 BioProcess International Awards. The ... social corporate responsibility and technology applications that will ... treatments to a global patient base. , Winners ... peers during a very entertaining and exciting awards ...
Breaking Biology Technology:Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4SoundConnect Unveils Q4 Partner Incentives 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5BioProcess International Announces Winners of the 2014 BioProcess International Awards 2BioProcess International Announces Winners of the 2014 BioProcess International Awards 3BioProcess International Announces Winners of the 2014 BioProcess International Awards 4BioProcess International Announces Winners of the 2014 BioProcess International Awards 5
... Votes "FOR" Required for Integra Merger, IRVINE, California, ... an orthobiologics company, today announced that,it has adjourned the ... approve the acquisition of IsoTis by Integra LifeSciences Holdings,Corporation ... and plan of,merger dated as of August 6, 2007. ...
... 24 Immunosyn,Corporation,s (OTC Bulletin Board: IMYN) CEO, ... financial institutions at the Financial,Services Exchange (FSX) Investment ... AZ on Thursday, October 25, 2007. Immunosyn ... to SF-1019 from its largest shareholder, Argyll,Biotechnologies, LLC. ...
... Spine Centers Committed to the IEP,s Rollout in ... Magnifi Group, considered by,many industry observers to be ... medical device and pharmaceutical industries,announced here today at ... intent to organize and develop real-time Internet-based 3D,interactive ...
Cached Biology Technology:IsoTis Adjourns Special Meeting to October 26, 2007 2IsoTis Adjourns Special Meeting to October 26, 2007 3IsoTis Adjourns Special Meeting to October 26, 2007 4Immunosyn Corporation to Present at FSX 2Magnifi Group Demonstrates Industry's First Interactive Educational Program (IEP) for Spine Fellows 2
(Date:10/28/2014)... to expand the Office of Rare Diseases Research ... Sciences (ORDR-NCATS) collaborative Rare Diseases Clinical Research Network ... 22 consortia will work with 98 patient advocacy ... treatments for patients with rare diseases. The collaborations ... 2014 funding from NIH. , Rett syndrome, MECP2 ...
(Date:10/28/2014)... Singapore (NTU Singapore) will be building a hybrid ... sources. , The first in the region, the ... of solar, wind, tidal-current, diesel, storage and power-to-gas ... together. , To be built under the new ... hybrid micro-grid will be located offshore at Semakau ...
(Date:10/27/2014)... Adélie penguins are an indigenous species of the West ... areas on Earth. Since 1950, the average annual temperature ... on average, and 6 degrees Celsius during winter. ... from a dry, polar system to a warmer, sub-polar ... recently reported a connection between local weather conditions and ...
Breaking Biology News(10 mins):NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 2NIH's ORDR-NCATS RDCRN & NICHD awards U54 cooperative agreement for natural history study 3NTU to build region's first renewable energy integration demonstration micro-grid 2NTU to build region's first renewable energy integration demonstration micro-grid 3University of Delaware study connects penguin chick weights to local weather conditions 2University of Delaware study connects penguin chick weights to local weather conditions 3
... expression of genes by turning them on or off at ... or cure of many diseases, say researchers at UT Southwestern ... of malfunctioning gene expression, or viral or bacterial gene expression," ... is an approach that could theoretically produce a drug for ...
... Vegetal of the Department of Agricultural Production at the ... for the best research in the area of viticulture. ... of Horticultural Science recently held in Oporto (Portugal). The ... grape varieties after a hydric stress event", studied the ...
... spent more than two decades leading efforts to combat ... relief supplies of antiretroviral therapies currently being distributed in ... those who can least afford to pay for them. ... of Public Health online June 28, infectious disease specialist ...
Cached Biology News:Gene silencing technique offers new strategy for treating, curing disease 2Best research work in the area of wine growing 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 4
... 3-D Shaker , ,Product Information ... the GyroTwister GX-1000 is extremely efficient, yet ... mixing as well as staining gels, hybridization ... adjustable across a broad range. A nonslip ...
... Scientific ChromQuest Chromatography Data System (CDS) ... data acquisition, chromatography data processing and ... High Speed LC. The companys innovative ... maximize the benefits of Thermo Scientific ...
... robotic system and disposable ESI Chip allow ... capabilities of electrospray mass spectrometers for life ... allows users to either speed analysis for ... mapping applications, or long acquisition times for ...
... coli Biotinylation Kit, Linear Template is designed for ... kits. (Cat. No. 3 186 148, 3 186 ... linear expression constructs by PCR containing and optimized ... of T7 RNA polymerase and prokaryotic cell lysate. ...
Biology Products: